Update on Stevens–Johnson syndrome and toxic epidermal necrolysis: diagnosis and management

H Shah, R Parisi, E Mukherjee, EJ Phillips… - American Journal of …, 2024 - Springer
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the most
severe cutaneous adverse reactions that are typically drug-induced in adults. Both SJS and …

HMGB1: a double-edged sword and therapeutic target in the female reproductive system

Y Ren, D Zhu, X Han, Q Zhang, B Chen… - Frontiers in …, 2023 - frontiersin.org
HMGB1 that belongs to the High Mobility Group-box superfamily, is a nonhistone chromatin
associated transcription factor. It is present in the nucleus of eukaryotes and can be actively …

An In Vitro Human Skin Test for Predicting Skin Sensitization and Adverse Immune Reactions to Biologics

SS Ahmed, MM Ahmed, A Ishaq, M Freer, R Stebbings… - Toxics, 2024 - mdpi.com
Biologics, including monoclonal antibodies (mAb), have proved to be effective and
successful therapeutic agents, particularly in the treatment of cancer and immune …

A systematic review of case–control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis

TJ Stewart, J Farrell, JW Frew - Australasian Journal of …, 2024 - Wiley Online Library
Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe
cutaneous adverse reactions characterised by keratinocyte apoptosis, necroptosis and …

Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic …

ED Ogiji, N Aboheimed, K Ross, C Voller… - Current Opinion in …, 2024 - journals.lww.com
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson
syndrome/toxic epidermal necrolysis can she Page 1 ACI 240409 CURRENT OPINION Greater …

[引用][C] Evaluation of novel therapeutics for the treatment of severe skin blistering adverse drug reactions.

D Carr